TEVA-GABAPENTIN DIN 02248457

Status: Marketed

Holder: TEVA CANADA LIMITED

Available to quote

Health Canada record

Active ingredient(s)	GABAPENTIN 600 MG
Dosage form	Tablet
Route	Oral
Schedule	PRESCRIPTION
Class	Human
ATC	N02BF01 GABAPENTIN
Original market date	19-Nov-2003
Current status date	21-Apr-2010
Source	Health Canada DPD

Establishment licence of the holder

Teva Canada Limited — licence 101810, currently licensed, last inspection rating C (2025-03-04).

Canadian shortage reports

Status	Reason	Estimated resolution	Tier	Updated
active	600MG			2026-09-04
active	400MG			2026-09-04

Other Canadian products containing GABAPENTIN

DIN	Product	Company	Form	Strength	Status
02244304	APO-GABAPENTIN	APOTEX INC	Capsule	GABAPENTIN 100 MG	Marketed
02293358	APO-GABAPENTIN	APOTEX INC	Tablet	GABAPENTIN 600 MG	Marketed
02244306	APO-GABAPENTIN	APOTEX INC	Capsule	GABAPENTIN 400 MG	Marketed
02244305	APO-GABAPENTIN	APOTEX INC	Capsule	GABAPENTIN 300 MG	Marketed
02246314	GABAPENTIN	SIVEM PHARMACEUTICALS ULC	Capsule	GABAPENTIN 100 MG	Marketed
02246316	GABAPENTIN	SIVEM PHARMACEUTICALS ULC	Capsule	GABAPENTIN 400 MG	Marketed
02246315	GABAPENTIN	SIVEM PHARMACEUTICALS ULC	Capsule	GABAPENTIN 300 MG	Marketed
02084287	NEURONTIN	BGP PHARMA ULC	Capsule	GABAPENTIN 400 MG	Marketed
02239717	NEURONTIN	BGP PHARMA ULC	Tablet	GABAPENTIN 600 MG	Marketed
02239718	NEURONTIN	BGP PHARMA ULC	Tablet	GABAPENTIN 800 MG	Marketed
02084260	NEURONTIN	BGP PHARMA ULC	Capsule	GABAPENTIN 100 MG	Marketed
02084279	NEURONTIN	BGP PHARMA ULC	Capsule	GABAPENTIN 300 MG	Marketed
02243446	PMS-GABAPENTIN	PHARMASCIENCE INC	Capsule	GABAPENTIN 100 MG	Marketed
02243447	PMS-GABAPENTIN	PHARMASCIENCE INC	Capsule	GABAPENTIN 300 MG	Marketed
02243448	PMS-GABAPENTIN	PHARMASCIENCE INC	Capsule	GABAPENTIN 400 MG	Marketed
02259796	RIVA-GABAPENTIN	LABORATOIRE RIVA INC.	Tablet	GABAPENTIN 600 MG	Marketed
02251167	RIVA-GABAPENTIN	LABORATOIRE RIVA INC.	Capsule	GABAPENTIN 100 MG	Marketed
02251175	RIVA-GABAPENTIN	LABORATOIRE RIVA INC.	Capsule	GABAPENTIN 300 MG	Marketed
02251183	RIVA-GABAPENTIN	LABORATOIRE RIVA INC.	Capsule	GABAPENTIN 400 MG	Marketed
02259818	RIVA-GABAPENTIN	LABORATOIRE RIVA INC.	Tablet	GABAPENTIN 800 MG	Marketed
02247346	TEVA-GABAPENTIN	TEVA CANADA LIMITED	Tablet	GABAPENTIN 800 MG	Marketed
02244515	TEVA-GABAPENTIN	TEVA CANADA LIMITED	Capsule	GABAPENTIN 400 MG	Marketed
02244514	TEVA-GABAPENTIN	TEVA CANADA LIMITED	Capsule	GABAPENTIN 300 MG	Marketed
02244513	TEVA-GABAPENTIN	TEVA CANADA LIMITED	Capsule	GABAPENTIN 100 MG	Marketed
02256169	ACT GABAPENTIN	ACTAVIS PHARMA COMPANY	Capsule	GABAPENTIN 400 MG	Cancelled Post Market
02256142	ACT GABAPENTIN	ACTAVIS PHARMA COMPANY	Capsule	GABAPENTIN 100 MG	Cancelled Post Market
02256150	ACT GABAPENTIN	ACTAVIS PHARMA COMPANY	Capsule	GABAPENTIN 300 MG	Cancelled Post Market
02266768	BCI GABAPENTIN	BAKER CUMMINS INC	Capsule	GABAPENTIN 300 MG	Cancelled Pre Market
02258153	DOM-GABAPENTIN	DOMINION PHARMACAL	Tablet	GABAPENTIN 600 MG	Cancelled Pre Market
02258161	DOM-GABAPENTIN	DOMINION PHARMACAL	Tablet	GABAPENTIN 800 MG	Cancelled Pre Market
02243745	DOM-GABAPENTIN	DOMINION PHARMACAL	Capsule	GABAPENTIN 400 MG	Cancelled Post Market
02243744	DOM-GABAPENTIN	DOMINION PHARMACAL	Capsule	GABAPENTIN 300 MG	Cancelled Post Market
02243743	DOM-GABAPENTIN	DOMINION PHARMACAL	Capsule	GABAPENTIN 100 MG	Cancelled Post Market
02238672	GABAPENTIN	OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.	Capsule	GABAPENTIN 300 MG	Cancelled Pre Market
02273853	GABAPENTIN	GENPHARM ULC	Capsule	GABAPENTIN 300 MG	Cancelled Post Market
02238673	GABAPENTIN	OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.	Capsule	GABAPENTIN 400 MG	Cancelled Pre Market
02238671	GABAPENTIN	OMNI LABORATORIES DIVISION, WARNER-LAMBERT CANADA INC.	Capsule	GABAPENTIN 100 MG	Cancelled Pre Market
02285835	GD-GABAPENTIN	GENMED A DIVISION OF PFIZER CANADA ULC	Capsule	GABAPENTIN 400 MG	Cancelled Post Market
02285827	GD-GABAPENTIN	GENMED A DIVISION OF PFIZER CANADA ULC	Capsule	GABAPENTIN 300 MG	Cancelled Post Market
02285843	GD-GABAPENTIN	GENMED A DIVISION OF PFIZER CANADA ULC	Tablet	GABAPENTIN 600 MG	Cancelled Post Market
02285851	GD-GABAPENTIN	GENMED A DIVISION OF PFIZER CANADA ULC	Tablet	GABAPENTIN 800 MG	Cancelled Post Market
02285819	GD-GABAPENTIN	GENMED A DIVISION OF PFIZER CANADA ULC	Capsule	GABAPENTIN 100 MG	Cancelled Post Market
02248259	MYLAN-GABAPENTIN	MYLAN PHARMACEUTICALS ULC	Capsule	GABAPENTIN 100 MG	Cancelled Post Market
02248260	MYLAN-GABAPENTIN	MYLAN PHARMACEUTICALS ULC	Capsule	GABAPENTIN 300 MG	Cancelled Post Market
02248261	MYLAN-GABAPENTIN	MYLAN PHARMACEUTICALS ULC	Capsule	GABAPENTIN 400 MG	Cancelled Post Market
02246744	NU-GABAPENTIN CAPSULES	NU-PHARM INC	Capsule	GABAPENTIN 400 MG	Cancelled (Unreturned Annual)
02246742	NU-GABAPENTIN CAPSULES	NU-PHARM INC	Capsule	GABAPENTIN 100 MG	Cancelled (Unreturned Annual)
02246743	NU-GABAPENTIN CAPSULES	NU-PHARM INC	Capsule	GABAPENTIN 300 MG	Cancelled (Unreturned Annual)
02258013	PHL-GABAPENTIN	PHARMEL INC	Tablet	GABAPENTIN 800 MG	Cancelled Post Market
02258005	PHL-GABAPENTIN	PHARMEL INC	Tablet	GABAPENTIN 600 MG	Cancelled Post Market
02255901	PMS-GABAPENTIN	PHARMASCIENCE INC	Tablet	GABAPENTIN 800 MG	Cancelled Post Market
02255898	PMS-GABAPENTIN	PHARMASCIENCE INC	Tablet	GABAPENTIN 600 MG	Cancelled Post Market
02260913	RATIO-GABAPENTIN	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Tablet	GABAPENTIN 600 MG	Cancelled Post Market
02260921	RATIO-GABAPENTIN	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Tablet	GABAPENTIN 800 MG	Cancelled Post Market
02260905	RATIO-GABAPENTIN	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Capsule	GABAPENTIN 400 MG	Cancelled Post Market
02260891	RATIO-GABAPENTIN	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Capsule	GABAPENTIN 300 MG	Cancelled Post Market
02260883	RATIO-GABAPENTIN	RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED	Capsule	GABAPENTIN 100 MG	Cancelled Post Market
02250926	TARO-GABAPENTIN	TARO PHARMACEUTICALS INC	Capsule	GABAPENTIN 400 MG	Cancelled Pre Market
02250918	TARO-GABAPENTIN	TARO PHARMACEUTICALS INC	Capsule	GABAPENTIN 300 MG	Cancelled Pre Market
02250888	TARO-GABAPENTIN	TARO PHARMACEUTICALS INC	Capsule	GABAPENTIN 100 MG	Cancelled Pre Market

Notices of Compliance

NOC	Date	Submission	Reason
11268	2010-04-20	Abbreviated New Drug Submission (ANDS)	Manufacturer and product name change
927	2003-11-19	Supplement to an Abbreviated New Drug Submission (SANDS)	NEW STRENGTH

International API supply for GABAPENTIN

19 valid EDQM Certificates of Suitability from 19 holders. 31 active FDA Drug Master Files.

Request a quote for TEVA-GABAPENTIN

How to read a Canadian DIN record